mesenchymal stem cells
Phase 3Cell therapy
mesenchymal stem cells is one of 1006 small molecule programs targeting HIV infection. It is currently in Phase 3.
45
Indications
91
Total Trials
16
Active Trials
1,005
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 44 indications
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1mesenchymal stem cells
JJiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 3
Singulair
AstraZenecaPreclinical
Activella
Eli LillyPreclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Glucocorticoid
AbbViePreclinical
Orap
TevaPreclinical
Biological Data
UUniversity Hospital, Bordeaux
Preclinical
Blood Taken
HHospices Civils de Lyon
Preclinical
Interferon-Gamma
SSPP Pharmaclon Ltd.
Preclinical
Biological Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Mesenchymal Stem Cells14 trials
Show 11 more trials
Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD
Completed·NNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan·Phase 1/2·NCT02824653·10 enrolled
Treatment of Gingival Recession Using Mesenchymal Stem Cells
Completed·IInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus·Phase 1/2·NCT04434794·27 enrolled
Mesenchymal Stem Cell4 trials
Multiple Sclerosis4 trials
Show 1 more trial
Acute Graft Versus Host Disease3 trials
Liver Transplant3 trials
52 more indications
Ischemia2 trials
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
Unknown status·FFederal Research Clinical Center of Federal Medical & Biological Agency, Russia·Phase 1/2·NCT03239535·40 enrolled
Type 2 Diabetes Mellitus2 trials
Systemic Lupus Erythematosus2 trials
Treatment2 trials
Type 1 Diabetes2 trials
Chronic Pancreatitis2 trials
Chronic Graft Versus Host Disease2 trials
Acute Respiratory Distress Syndrome2 trials
Proctitis2 trials
Heart Failure2 trials
Cirrhosis2 trials
Hematopoietic Stem Cell Transplant1 trial
Acute Kidney Injury1 trial
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
Unknown status·—·Phase 1/2·NCT04194671·80 enrolled
Osteogenesis Imperfecta1 trial
Kidney Disease1 trial
Kidney Transplant1 trial
To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients
Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 1·NCT02409940·17 enrolled
HIV infection1 trial
Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection
Unknown status·SShandong Qilu Cell Therapy Engineering Technology Co., Ltd·Phase 1·NCT05872659·20 enrolled
Stem Cells1 trial
Osteoarthritis1 trial
Encephalopathy1 trial
Cystic Fibrosis1 trial
Periodontitis1 trial
Diabetic Foot1 trial
Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot
Unknown status·—·Phase 1·NCT02304588·20 enrolled
Liver1 trial
Brain Injury1 trial
Psoriasis1 trial
Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells
Unknown status·—·Phase 1·NCT03765957·12 enrolled
Complication1 trial
Severe Aplastic Anemia1 trial
Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.
Unknown status·GGuangzhou General Hospital of Guangzhou Military Command·Phase 2·NCT02247973·100 enrolled
Spinal Cord Injury1 trial
Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study
Completed·NNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan·Phase 1·NCT02482194·9 enrolled
Ischemic Cardiomyopathy1 trial
Emphysema1 trial
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
Withdrawn·FFederal Research Clinical Center of Federal Medical & Biological Agency, Russia·Phase 1/2·NCT01849159
Chronic Obstructive Pulmonary Disease1 trial
Rotator Cuff Tear1 trial
MSCs1 trial
Ischemic stroke1 trial
Anal fistula1 trial
COVID-191 trial
Mesenchymal Stem Cell Infusion for COVID-19 Infection
Unknown status·—·Phase 2·NCT04444271·20 enrolled
Hematopoietic Stem Cell Transplantation1 trial
Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies
Completed·—·Phase 3·NCT03106662·6 enrolled
Autoimmune Disease1 trial
Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Enrolling by invitation·NNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan·Phase 1/2·NCT06888973·200 enrolled
Androgenetic Alopecia1 trial
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.
Enrolling by invitation·NNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan·Phase 1/2·NCT06764329·70 enrolled
Mesenchymal Stromal Cells1 trial
Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction
Recruiting·IInstituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana·Phase 1·NCT06514378·12 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for mesenchymal stem cells. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details